Allergan agrees to Actavis deal for $66 billion Allergan has agreed to be bought by Actavis for $66 billion, putting an end to a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals. Business • 17 Nov 14
Allergan agrees to Actavis deal for $66 billion Allergan has agreed to be bought by Actavis for $66 billion, putting an end to a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals. Business • 17 Nov 14
Actavis buying Warner Chilcott for $8.5 billion Pharmaceutical company Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5 billion. Business • 20 May 13
Actavis buying Warner Chilcott for $8.5 billion Pharmaceutical company Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5 billion. Business • 20 May 13
